Ghent University Academic Bibliography

Book Chapter

Current state of mRNA vaccine development against Mycobacterium tuberculosis

Ilke Aernout (UGent) , Rein Verbeke (UGent) , Stefaan De Smedt (UGent) , Francis Impens (UGent) and Ine Lentacker (UGent)

(2025) Trends in mRNA vaccine research. p.325-335

Add to list

Journal Article
A1
open access

mRNA galsomes vaccine protects budgerigars against virulent Chlamydia psittaci challenge

Anne De Meyst (UGent) , Joeri Van Mieghem, Koen Chiers (UGent) , Koen Raemdonck (UGent) , Rein Verbeke (UGent) , Ine Lentacker (UGent) and Daisy Vanrompay (UGent)

(2025) VACCINES. 13(2).

Add to list

Journal Article
A1
open access

Considerations on the design of lipid-based mRNA vaccines against cancer

Sofie Meulewaeter (UGent) , Yao Zhang, Abishek Wadhwa, Kevin Fox, Ine Lentacker (UGent) , Kenneth W. Harder, Pieter R. Cullis, Stefaan De Smedt (UGent) , Miffy H.Y. Cheng and Rein Verbeke (UGent)

(2024) JOURNAL OF MOLECULAR BIOLOGY. 436(2).

Add to list

Journal Article
A1
open access

Alpha-galactosylceramide improves the potency of mRNA LNP vaccines against cancer and intracellular bacteria

Sofie Meulewaeter (UGent) , Ilke Aernout (UGent) , Joke Deprez (UGent) , Yanou Engelen (UGent) , Margo De Velder (UGent) , Lorenzo Franceschini, Karine Breckpot, Serge Van Calenbergh (UGent) , Caroline Asselman (UGent) , Katie Boucher (UGent) , et al.

(2024) JOURNAL OF CONTROLLED RELEASE. 370. p.379-391

Add to list

Journal Article
A1
open access

Immunopeptidomics mapping of Listeria monocytogenes T cell epitopes in mice

Adillah Gul (UGent) , Lecia L. Pewe, Patrick Willems (UGent) , Rupert Mayer (UGent) , Fabien Henri Thery (UGent) , Caroline Asselman (UGent) , Ilke Aernout (UGent) , Rein Verbeke (UGent) , Denzel Eggermont (UGent) , Laura Van Moortel (UGent) , et al.

(2024) MOLECULAR & CELLULAR PROTEOMICS. 23(9).

Add to list

Journal Article
A1
open access

Selective replacement of cholesterol with cationic amphiphilic drugs enables the design of lipid nanoparticles with improved RNA delivery

Bram Bogaert, Aliona Debisschop (UGent) , Thomas Ehouarne (UGent) , Hannelore Van Eeckhoutte, Joyceline De Volder (UGent) , An Jacobs, Eline Pottie (UGent) , Riet De Rycke (UGent) , Aurélie Crabbé (UGent) , Pieter Mestdagh (UGent) , et al.

(2024) NANO LETTERS. 24(10). p.2961-2971

Add to list

Nanomedicine to aid immunogenic cell death (ICD)-based anticancer therapy

Robin Demuynck (UGent) , Yanou Engelen (UGent) , Andre Skirtach (UGent) , Stefaan De Smedt (UGent) , Ine Lentacker (UGent) and Dmitri Krysko (UGent)

(2024) TRENDS IN CANCER. 10(6). p.486-489

Add to list

Optimizing high-intensity focused ultrasound-induced immunogenic cell-death using passive cavitation mapping as a monitoring tool

Yanou Engelen (UGent) , Dmitri Krysko (UGent) , Iuliia Efimova (UGent) , Karine Breckpot, Michel Versluis, Stefaan De Smedt (UGent) , Guillaume Lajoinie and Ine Lentacker (UGent)

(2024) JOURNAL OF CONTROLLED RELEASE. 375. p.389-403

Add to list

Journal Article
A1
open access

The role of mRNA-galsomes and LNPs in enhancing HIV-specific T cell responses across various lymphoid organs

Sigrid D’haese, Sabine den Roover, Rein Verbeke (UGent) , Ilke Aernout (UGent) , Sofie Meulewater, Joëlle Cosyns, Jessy Meert, Sarah Vanbellingen, Thessa Laeremans, Ine Lentacker (UGent) , et al.

(2024) MOLECULAR THERAPY NUCLEIC ACIDS. 35(4).

Add to list

Laser-induced vapor nanobubbles for B16-F10 melanoma cell killing and intracellular delivery of chemotherapeutics

Jana Ramon (UGent) , Yanou Engelen (UGent) , Herlinde De Keersmaecker (UGent) , Ilia Goemaere (UGent) , Deep Punj (UGent) , Julián Mejía Morales (UGent) , Cédric Bonte, Geert Berx (UGent) , Esther Hoste (UGent) , Stephan Stremersch, et al.

(2024) JOURNAL OF CONTROLLED RELEASE. 365. p.1019-1036

Academic Bibliography

Current state of mRNA vaccine development against Mycobacterium tuberculosis

mRNA galsomes vaccine protects budgerigars against virulent Chlamydia psittaci challenge

Considerations on the design of lipid-based mRNA vaccines against cancer

Alpha-galactosylceramide improves the potency of mRNA LNP vaccines against cancer and intracellular bacteria

Immunopeptidomics mapping of Listeria monocytogenes T cell epitopes in mice

Selective replacement of cholesterol with cationic amphiphilic drugs enables the design of lipid nanoparticles with improved RNA delivery

Nanomedicine to aid immunogenic cell death (ICD)-based anticancer therapy

Optimizing high-intensity focused ultrasound-induced immunogenic cell-death using passive cavitation mapping as a monitoring tool

The role of mRNA-galsomes and LNPs in enhancing HIV-specific T cell responses across various lymphoid organs

Laser-induced vapor nanobubbles for B16-F10 melanoma cell killing and intracellular delivery of chemotherapeutics

Contents

Support

Contact